The U.S. Senate on Friday unanimously approved a one-week extension of federal funding to avoid a government shutdown this weekend and to provide more time for separate negotiations on COVID-19 relief and an overarching spending bill. With the Senate’s vote the measure now goes to President Donald Trump for signing into law.
FDA to authorize Pfizer vaccine in ‘couple of days’ – Azar
Get the damn vaccines out now!’ Trump rages at ‘slow turtle’ FDA for taking so long to approve Pfizer vaccine and tells them ‘stop playing games and start saving lives’ – as Azar says approval may still take ‘a couple of days’
- Trump tweeted on Friday that the FDA was a ‘slow turtle’ taking too long to approve the vaccine
- Health and Human Services Secretary Alex Azar said that the FDA ‘told Pfizer it intends to proceed with approval’ but that they were still ‘negotiating’
- It could take several days, he said, before approval is actually given much less rolled out across the country
- He claims the first shots in the arm will be on Monday and Tuesday next week but it’s unclear where
- Meanwhile on Wednesday, the US had its deadliest day yet with 3,144 deaths
- Twenty-three scientists met on Thursday to discuss if the vaccine was safe and effective
- They have recommended to the FDA that it should be approved but it still hasn’t
- Both the UK and Canada approved have already approved vaccine
President Donald Trump raged at the FDA for taking so long to approve Pfizer’s COVID vaccine on Friday morning and ordered them to ‘stop playing games and start saving lives’ as Health and Human Services Secretary Alex Azar said official approval may still take ‘a couple of days’. A panel of 23 independent scientists voted in favor of the vaccine on Thursday and recommended it to the FDA after a day of long, drawn-out talks over whether or not it is safe. But the FDA still has not officially given it approval and the first doses haven’t been distributed yet, even though the UK and Canada have both given it the green light. Health and Human Services Alex Azar says the FDA has told Pfizer it ‘intends to approve’ its COVID vaccine after an excruciating two-and-a-half week wait but inexplicably, it still hasn’t and there is still no date for when the first people will receive it in America. Speaking on Good Morning America, he said: ‘I’ve got some good news for you. Just a little bit ago, the FDA informed Pfizer that they intends to proceed towards approval for its vaccine. ‘In the next couple of days probably as we work to negotiate with Pfizer the information doctors need to prescribe appropriately, we should be seeing the authorization and we’ll be working with Pfizer to get that shipped out so we could be seeing people getting vaccinated Monday, Tuesday of next week.’
Scroll down for video
Speaking on Good Morning America, Health and Human Services Alex Azar says the FDA has told Pfizer it ‘intends to approve’ its COVID vaccine after an excruciating two-and-a-half week wait but inexplicably, it still hasn’t
Coronavirus relief talks stalled in Congress as deadlines inch closer
Congress is preparing to potentially work through the holidays until they can pass more coronavirus aid for the country. CBS News chief congressional correspondent Nancy Cordes, CBS News political correspondent Ed O’Keefe, and NPR White House correspondent Tamara Keith spoke to “Red and Blue” host Elaine Quijano about where negotiations stand, as well as the latest from the outgoing Trump administration and the incoming Biden transition team. Nick Note: Hang tight their will be a deal!
FDA panel recommends Pfizer’s COVID-19 vaccine approval
A federal advisory panel on Thursday recommended the emergency use of Pfizer’s COVID-19 vaccine. The Food and Drug Administration is expected to approve the drug, kicking off a massive nationwide operation to get nearly 3 million doses of the vaccine to hospitals and drug stores across the country. “We’ve been working very closely with our state and local partners to make sure they have plans in place to identify providers that are able to receive, store and use the vaccine,” said Dr. Anita Patel, deputy of the CDC’s vaccine task force. The experts voted 17 to 4 in favor of recommending the drug for emergency use for people aged 16 years and older, with one of the members withholding. Health care workers and nursing home residents will be among the first to get the vaccine.
A lot of progress made on stimulus – Mnuchin
US Treasury Secretary Steven Mnuchin has said that senators from both parties are making progress on stimulus talks and more meetings are scheduled for later on Thursday. House Speaker Nancy Pelosi is set to speak later on. The S&P 500 Index has returned to positive territory after trading lower earlier in the day. Mnuchin has said that senators from both parties are making progress on stimulus talks and more meetings are scheduled for later on Thursday. House Speaker Nancy Pelosi is set to speak later on.
Stocks Drop, Bonds Rise Amid Stimulus Stalemate: Markets Wrap
(Bloomberg) — Stocks fell on concern that prospects for a stimulus deal remain elusive amid the most-intense negotiations over a Covid-19 package since Election Day. The S&P 500 also dropped after data showed applications for U.S. unemployment benefits surged last week, topping most estimates. Technology shares continued to underperform, with Facebook Inc. slipping further as the U.S. Federal Trade Commission took a major step toward a possible breakup of the social-media giant by filing an antitrust lawsuit. Airbnb Inc. will start trading Thursday after DoorDash Inc. supercharged investor expectations by almost doubling in its frenzied public debut. Senate Majority Leader Mitch McConnell and House Speaker Nancy Pelosi have given no sign yet that they’re ready to directly engage in negotiations to sort through competing pandemic relief proposals — a step that many lawmakers say will be necessary to complete a deal this month. Meanwhile, House Republican Leader Kevin McCarthy told CNBC that he sees a deal done next week. Elsewhere, the euro rose after policy makers escalated their efforts to shield the region from a possible double-dip recession with another burst of monetary stimulus, while cautioning that it may not use up all the new firepower. The pound fell as negotiations between the U.K. and the European Union were seen on course to end without a trade deal. Surges in Doordash Inc. and C3.ai Inc. on the first day of trading were in keeping with rising speculation for U.S. stock investors, according to Jonthan Krinsky, chief market technician at Bay Crest Partners LLC, who cited the Renaissance IPO and IPOX SPAC indexes. Renaissance Capital LLC’s gauge of initial public offerings rose 32% from a late-October low through Tuesday. In a similar period, IPOX Schuster LLC’s index of current and former blank-check companies climbed 40%. The IPO index fell 3.2% Wednesday even as Doordash gained 86% and C3.ai jumped 120%. The SPAC index rose 0.3%.
More Americans are shoplifting food as aid runs out during the pandemic
The coronavirus recession has been a relentless churn of high unemployment and economic uncertainty. The government stimulus that kept millions of Americans from falling into poverty earlier in the pandemic is long gone, and new aid is still a dot on the horizon after months of congressional inaction. Hunger is chronic, at levels not seen in decades. The result is a growing subset of Americans who are stealing food to survive. Shoplifting is up markedly since the pandemic began in the spring and at higher levels than in past economic downturns, according to interviews with more than a dozen retailers, security experts and police departments across the country. But what’s distinctive about this trend, experts say, is what’s being taken – more staples like bread, pasta and baby formula. “We’re seeing an increase in low-impact crimes,” said Jeff Zisner, chief executive of workplace security firm Aegis. “It’s not a whole lot of people going in, grabbing TVs and running out the front door. It’s a very different kind of crime – it’s people stealing consumables and items associated with children and babies.” With Americans being advised to brace for a difficult winter amid skyrocketing coronavirus infection rates and the economic recovery nearly stalled, the near-term outlook is grim. More than 20 million Americans are on some form of unemployment assistance, and 12 million will run out of benefits the day after Christmas unless new relief materializes. Though lawmakers have made progress this week on a $908 billion bill, details are still being worked out, congressional aides said. Meanwhile, an estimated 54 million Americans will struggle with hunger this year, a 45% increase from 2019, according to the U.S. Department of Agriculture. With food aid programs like SNAP and WIC being reduced, and other federal assistance on the brink of expiration, food banks and pantries are being inundated, reporting hours-long waits and lines that stretch into the thousands. Several federal food programs that have provided billions of dollars in fresh produce, dairy and meat to U.S. food banks also are set to expire at the end of the year. The largest among them, the Farmers to Families Food Box, has provided more than 120 million food boxes during the pandemic and is already running out of funding in many parts of the country. With the United States now registering more than 150,000 new cases a day, some communities are reintroducing restrictions in an effort to contain the virus. Most of California is now under strict stay-at-home orders, for example, while states including Nevada, Maryland and Pennsylvania have issued new indoor occupancy limits. Such orders tend to hit already vulnerable workers in low-wage service jobs in restaurants, retail and bars the hardest. Nearly 26 million adults – or 1 in 8 Americans – reported not having enough food to eat as of mid-November, according to the latest data from the Census Bureau. That figure has climbed steadily during the pandemic, and has hit record highs since the government agency began collecting such data in 1998.
Ivermectin And Doxycycline To Treat Mild/Moderate COVID-19: Randomized, Double Blinded, Placebo Ctrl
https://youtu.be/5MNsM-ZhRS4
This video we will discuss and review a trial from ClinicalTrials.gov that have reported their results, but not published them. It is a randomized, double blinded, placebo control trial out of Bangladesh comparing treatment with Ivermectin and Doxycycline with standard care (tylenol, vitamin D, steroids as needed, oxygen as needed, etc) versus standard care alone. Their reported results were quite impressive. They reported increased clinical improvement at 7 days, decreased clinical deterioration at 30 days, and decreased viral loads at 14 days in those who received IVM and Doxy! Were there any adverse effects? Check out the video for all the details! Link to the study below:
Called a Miracle Anti Viral Ivermectin
Ivermectin Works For COVID-19 – LATEST STUDIES
https://youtu.be/V4fEBK1inj4
Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019
Link Here: https://doi.org/10.1016/j.chest.2020.10.009
Original in-vitro study about Ivermectin https://www.ncbi.nlm.nih.gov/pmc/arti…
A study from bangladesh found that Ivermectin + Doxyclyclin significantly reduces mortality and morbidity in COVID-19 patients. https://clinicaltrials.gov/ct2/show/s…
A systemic review of the antiviral activity of Ivermectin https://www.nature.com/articles/s4142… https://journal.chestnet.org/article/… PDF for the above study after it was accepted
https://journal.chestnet.org/article/… Pre-print of the above study https://www.medrxiv.org/content/10.11…
A search of various Ivermectin studies for your reading pleasure https://clinicaltrials.gov/ct2/result…
Iota carrageenan and Ivermectin oral drops https://clinicaltrials.gov/ct2/show/r…
Here is a index of the Clinical studies I have reviewed their are 44 of what i call suppressed studies. Think about it big Pharah has been given world wide 250 billion for the various vaccines. The medicines in the studies cost pennies a dose. Big Pharma wins the and over 2 million people dead have lost. they did not have to die:
https://clinicaltrials.gov/ct2/results?cond=Covid19&term=ivermectin&cntry&state&city&dist